ストックスクリーナーアプリを入手
2.07
0.48%
-0.01
前日終値:
$2.08
開ける：
$2.06
24時間の取引高:
309.62K
Relative Volume:
1.26
時価総額：
$115.38M
収益：
$14.18M
当期純損益:
$-82.66M
株価収益率:
-1.5923
EPS:
-1.3
ネットキャッシュフロー:
$-50.80M
1週間 パフォーマンス:
+12.50%
1か月 パフォーマンス:
+4.55%
6か月 パフォーマンス:
-10.39%
1年 パフォーマンス:
-2.36%
1日の値動き範囲:
$2.03
$2.11
1週間の範囲:
$1.84
$2.3351
52週間の値動き範囲:
$1.56
$2.625
Seer Inc Stock (SEER) Company Profile
SEER を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
SEER
Seer Inc
|
2.07 | 109.35M | 14.18M | -82.66M | -50.80M | -1.30 |
|
ONC
Beigene Ltd Adr
|
228.38 | 25.07B | 3.81B | -644.79M | -669.77M | -6.24 |
|
VRTX
Vertex Pharmaceuticals Inc
|
438.65 | 109.14B | 11.10B | -988.90M | -1.26B | -3.92 |
|
AKTX
Akari Therapeutics Plc Adr
|
1.27 | 36.39M | 0 | 0 | 0 | 0.00 |
|
REGN
Regeneron Pharmaceuticals Inc
|
594.32 | 56.98B | 14.09B | 4.50B | 2.96B | 39.28 |
|
VRNA
Verona Pharma Plc Adr
|
71.31 | 5.39B | 0 | -153.72M | -103.81M | -2.00 |
Seer Inc Stock (SEER) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2023-07-05 | 再開されました | JP Morgan | Neutral |
| 2023-01-04 | ダウングレード | BofA Securities | Neutral → Underperform |
| 2022-08-11 | ダウングレード | JP Morgan | Overweight → Neutral |
| 2021-10-15 | 再開されました | Cowen | Outperform |
| 2020-12-29 | 開始されました | BofA Securities | Neutral |
| 2020-12-29 | 開始されました | Cowen | Outperform |
| 2020-12-29 | 開始されました | JP Morgan | Overweight |
| 2020-12-29 | 開始されました | Morgan Stanley | Equal-Weight |
すべてを表示
Seer Inc (SEER) 最新ニュース
Seer reiterates $17M–$18M 2025 revenue guidance amid strong Q1 instrument demand and large-scale study momentum - MSN
US$3.00: That's What Analysts Think Seer, Inc. (NASDAQ:SEER) Is Worth After Its Latest Results - simplywall.st
Seer, Inc. Reports Strong Q1 2025 Earnings - TipRanks
Barclays PLC Decreases Stake in Seer, Inc. (NASDAQ:SEER) - Defense World
Seer, Inc. (SEER) Reports Q1 Loss, Tops Revenue Estimates - MSN
Seer, Inc. (NASDAQ:SEER) Q1 2025 Earnings Call Transcript - Insider Monkey
Seer (SEER) Anticipates Revenue Growth in 2025 | SEER Stock News - GuruFocus
Seer Inc (SEER) Q1 2025 Earnings Call Highlights: Strong Revenue Growth Amid Market Challenges - Yahoo Finance
Seer, Inc. Reports Strong Q1 2025 Growth - TipRanks
Seer Q1 2025 Earnings Call Transcript - MarketBeat
Seer (SEER) Surpasses Q1 Revenue Expectations with Strong Perfor - GuruFocus
Earnings call transcript: Seer Q1 2025 sees strong revenue growth, stock jumps - Investing.com Australia
Seer Inc reports results for the quarter ended March 31Earnings Summary - TradingView
Seer Inc (SEER) Q1 2025 Earnings: EPS of -$0.34 Beats Estimate, Revenue Surges to $4.2 Million - GuruFocus
Seer, Inc. Reports Strong First Quarter 2025 Financial Results with $4.2 Million in Revenue - Nasdaq
Seer Reports First Quarter 2025 Financial Results and Reiterates Full Year 2025 Outlook - GlobeNewswire
SpaceWorks Enterprises Inc. Integrates AI into Spaceflight Planning and National Defense Initiatives with SEERai, Galorath's AI-Powered Cost Estimation Platform - Morningstar
What To Expect From Seer Inc (SEER) Q1 2025 Earnings - GuruFocus
Seer (SEER) Expected to Announce Earnings on Tuesday - Defense World
Geode Capital Management LLC Decreases Position in Seer, Inc. (NASDAQ:SEER) - Defense World
Renaissance Technologies LLC Acquires 179,568 Shares of Seer, Inc. (NASDAQ:SEER) - The AM Reporter
Seer (NASDAQ:SEER) Shares Down 2.5% – What’s Next? - Defense World
Seer to Report First Quarter 2025 Financial Results on May 13, 2025 | SEER Stock News - GuruFocus
Seer to Report First Quarter 2025 Financial Results on May 13, 2025 - GlobeNewswire
Seer, Inc. to Report Q1 2025 Financial Results on May 13, 2025 - Nasdaq
Seer Earnings Preview: Proteomics Pioneer Readies Q1 2025 Financial Results for May 13 Release - Stock Titan
Veracyte data joins NCI SEER database for research - Investing.com
Seer Medical saved by $40 million rescue deal from global investors, Breakthrough Victoria - SmartCompany
Cadwell invests in Australian company Seer Medical - Yahoo
Cadwell Makes a Strategic Investment in Seer Medical to Expand Home-Based Epilepsy Diagnostics | Newswise - Newswise
Cadwell Makes a Strategic Investment in Seer Medical to Expand Home-Based Epilepsy Diagnostics - Yahoo Finance
Metagenomi Leads The Charge With These 3 Penny Stocks - simplywall.st
Seer : Immuneering to Present at the 24th Annual Needham Virtual Healthcare Conference - MarketScreener
Corient Private Wealth LLC Acquires 13,200 Shares of Seer, Inc. (NASDAQ:SEER) - Defense World
Seer Inc (SEER) may enjoy gains as insiders got busy in the recent days - knoxdaily.com
SEER LAUNCHES CARBON FOCUSED DIVISION TO PRODUCE LICENSED - GlobeNewswire
SEER LAUNCHES CARBON FOCUSED DIVISION TO PRODUCE LICENSED BIOCHAR, MONETIZE AND TOKENIZE ASSETS AND CARBON CREDITS AND DEVELOP TURBINE BLADE TREATMENT TECHNOLOGY - Yahoo
After Plunging -16.59% in 4 Weeks, Here's Why the Trend Might Reverse for Seer (SEER) - MSN
After Plunging -16.81% in 4 Weeks, Here's Why the Trend Might Reverse for Seer (SEER) - Yahoo Finance
Al Seer takes delivery of two new vessels - The Maritime Standard
Seer, Inc. (SEER) Reports Q4 Loss, Tops Revenue Estimates - MSN
Large Tools and Labs Optimistic at TD Cowen Health Conference By Investing.com - Investing.com Australia
Large Tools and Labs Optimistic at TD Cowen Health Conference - Investing.com India
Seer Inc (SEER) Q4 2024 Earnings Report Preview: What To Look Fo - GuruFocus.com
SEER, INC. : Results of Operations and Financial Condition (form 8-K) -January 25, 2021 at 04:40 pm EST - marketscreener.com
Down -10.53% in 4 Weeks, Here's Why Seer (SEER) Looks Ripe for a Turnaround - Yahoo Finance
Y Intercept Hong Kong Ltd Acquires New Shares in Seer, Inc. (NASDAQ:SEER) - Defense World
Seer, Inc. Earnings Call: Mixed Sentiment and Optimistic Outlook - TipRanks
Seer, Inc. SEC 10-K Report - TradingView
Seer Full Year 2024 Earnings: In Line With Expectations - Yahoo Finance
Seer Inc (SEER) 財務データ
収益
当期純利益
現金流量
EPS
Seer Inc (SEER) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| Farokhzad Omid | CEO AND CHAIR |
Feb 04 '25 |
Sale |
2.24 |
8,068 |
18,044 |
1,428,217 |
| Nishar Dipchand | Director |
Jun 14 '24 |
Sale |
1.78 |
12,109 |
21,512 |
79,457 |
1.54%
7.58%
大文字化:
|
ボリューム (24 時間):